Don’t miss the APIS team at BioTechX Europe!

APIS is leveraging systems biology and interrogating multi-OMICs biodata for the validation and translation of biomarker into clinical utility.

Utilising the transformational power of systems biology, innovative synthetic antibody technologies, and genomic big data APIS directly addresses the historical failures of translating biomarkers into clinical utility.

Operating under an ISO 13485 QMS, APIS seeks to develop and manufacture proprietary and client derived disease- and tissue-agnostic biomarkers as IVD tests (MDx, CDx and CoDx), maximising the benefit to both patients and stakeholders in either a centralised or de-centralised laboratory setting.

Use this link to contact us and schedule a meeting.